Acumen Pharmaceuticals (ABOS): filings, insider buys & geopolitical news
In the last 30 days, Geopolitics Alpha logged 1 item on Acumen Pharmaceuticals: 0 news stories, 1 SEC filing and 0 fund or insider trade reports. The latest filing was logged 26 Oct 2026: 8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer).
What changed for Acumen Pharmaceuticals (ABOS)
In the last 30 days, Geopolitics Alpha logged 1 item on Acumen Pharmaceuticals: 0 news stories, 1 SEC filing and 0 fund or insider trade reports. The latest filing was logged 26 Oct 2026: 8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer).
- 0 news
- 1 SEC filings
- 0 fund / insider trades
Latest SEC filings
Latest fund & insider buys and sales
None on record yet.
Latest geopolitical & market news
None on record yet.
Congressional trades in ABOS
Trades in ABOS that members of Congress have publicly reported, newest filing first.
No congressional trades are stored for this view yet.
All congressional stock trades →
Geopolitical news for ABOS
Everything on ABOS, newest first
- SEC filing 8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer)
26 Oct 2026, 11:09 UTC
Frequently asked questions
What geopolitical news affects ABOS?
This page lists every Geopolitics Alpha note that names ABOS as exposed to an event, with the reason it is exposed.
Has Congress traded ABOS?
The table above lists trades in ABOS that members of Congress have publicly reported, with a link to each official filing.
Is this investment advice?
No. We show news, exposure and past price moves. Nothing here is a recommendation.